Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 32022M10629

Commission Decision of 31/05/2022 declaring a concentration to be compatible with the common market (Case No COMP/M.10629 - CSL / VIFOR PHARMA) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

Legal status of the document In force